Benoit Hilbold

Title: Benoit Hilbold: Innovator in Pharmaceutical Formulations

Introduction

Benoit Hilbold is a notable inventor based in Schiltigheim, France. He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on the oral delivery of poorly permeable molecules. With a total of 2 patents to his name, his work is paving the way for advancements in drug delivery systems.

Latest Patents

Benoit Hilbold's latest patents include a formulation for oral delivery of proteins, peptides, and small molecules with poor permeability. This innovative pharmaceutical formulation is designed for the oral delivery of synthetic or natural poorly permeable molecules or salts/solvates that possess therapeutic activity. The formulation comprises a poorly permeable molecule or salt in an amount of 0.01-10 wt. % of the total weight, a lipophilic phase consisting of triglycerides of fatty acids in an amount of 50-80 wt. %, and at least one lipophilic surfactant made up of partial esters of polyol and fatty acids in an amount of about 10-50 wt. % of the total weight.

Career Highlights

Benoit is currently associated with R.P. Scherer Technologies, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in formulating effective drug delivery systems has garnered attention in the industry.

Collaborations

Benoit has collaborated with notable colleagues such as Vincent Plassat and Aurélia Galus, contributing to various projects that enhance the efficacy of pharmaceutical formulations.

Conclusion

Benoit Hilbold's work in pharmaceutical formulations exemplifies the importance of innovation in drug delivery systems. His contributions are vital for improving therapeutic outcomes for patients with poorly permeable molecules.